Not All Patients Are Equal and Your Business Depends on Knowing the Difference

By Peeq Pro | For Optometrists and Their Teams

Most optometry practices know what a patient spent during their last visit. Far fewer know what that patient is worth over the course of a 10-year relationship.

That number matters.

Patient lifetime value includes every comprehensive exam, medical visit, pair of glasses, contact lens order, dry eye product purchase, and advanced treatment a patient receives throughout their relationship with your practice. When you look at your patient base through that lens, a striking reality emerges: some patients generate dramatically more value than others.

The difference is rarely luck. It is not determined by geography or demographics. More often, it comes down to whether a practice has a system that identifies chronic conditions, supports ongoing care, and keeps patients engaged between visits.

Dry eye disease may be the clearest example.

The Lifetime Value Gap Most Practices Overlook

Our patient lifetime value modeling reveals just how significant the gap can be.

An irregular vision insurance patient who only comes in when they need new glasses generates roughly $275 in lifetime value over a decade.

At the other end of the spectrum, a patient who returns annually, utilizes medical insurance, purchases glasses and contact lenses, uses recommended products, and receives advanced treatments such as IPL can generate approximately $16,278 in lifetime value.

That is nearly 60 times more value from a single patient relationship.

The middle of the spectrum is just as revealing:

• Regular vision insurance patient (glasses only): approximately $1,130

• Regular medical insurance patient (no products or services): approximately $2,055

• Medical patient who purchases glasses, contacts, and products: approximately $4,110

• Full-service patient receiving ongoing dry eye care and treatments: approximately $16,278

The takeaway is simple. The patients creating the greatest long-term value are not necessarily different people. They are patients who have been guided into a broader care relationship with the practice.

That relationship often starts with dry eye.

Dry Eye Is Not a Product Problem

Dry eye disease is one of the most common conditions encountered in optometric practice, yet it remains significantly undertreated.

The issue is not a lack of products. The issue is adherence.

Patients leave the office with treatment recommendations, educational materials, and good intentions. A few weeks later, most have fallen off the protocol entirely.

Industry-wide adherence to dry eye home therapy sits at approximately 1.6%. In practical terms, that means roughly 98 out of every 100 patients prescribed a home treatment plan are no longer following it within a matter of months.

That is not a patient problem. It is a process problem.

Consider oral hygiene. We do not expect patients to develop lifelong brushing habits simply because a dentist mentioned it once. Habits form through reinforcement, education, reminders, accountability, and follow-up.

The same principle applies to ocular surface care.

DEWS II and DEWS III both support foundational therapies such as lid hygiene, lubrication, and meibomian gland maintenance. These interventions work when patients perform them consistently. Unfortunately, consistency is exactly where most treatment plans break down.

This is where workflow matters.

Through structured phone calls, text messages, and emails, Peeq Pro guides patients through the critical first weeks of treatment. Patients receive reminders, education, and coaching that help them establish sustainable habits.

The result is treatment adherence exceeding 30%, and more than 50% when a live conversation occurs.

Compared to the industry baseline, that represents a 13- to 30-fold improvement.

More importantly, patients who adhere to treatment begin seeing results. Those patients become more engaged, more invested in their eye health, and more likely to pursue additional care.

Why the OSDE Changes the Economics

Many practices diagnose dry eye during the comprehensive exam, provide recommendations, and schedule the next annual visit.

That approach leaves an enormous opportunity untapped.

A more effective model is to prescribe a Step One treatment plan, enroll the patient in a structured workflow, and schedule an Ocular Surface Disease Evaluation (OSDE) approximately 30 days later.

That simple change creates several important benefits.

First, it gives patients time to implement treatment and experience early improvements. By the time they return, they are no longer evaluating a theoretical recommendation. They are evaluating a treatment they have actually used.

Second, it significantly improves follow-up compliance.

Peeq Pro data shows approximately a 60% reduction in OSDE cancellations and no-shows among patients enrolled in the workflow. Patients who understand why the appointment matters and who have been actively engaged throughout the preceding month are substantially more likely to attend.

Third, patients arriving for the OSDE are dramatically more receptive to advanced treatment recommendations.

In fact, they are six times more likely to accept advanced therapies compared to patients who receive those recommendations immediately during the comprehensive exam.

That result is not surprising when viewed through the patient's perspective.

Over the preceding month, they have become more aware of their symptoms. They have invested effort into treatment. They understand that dry eye is a chronic condition requiring management. When advanced therapies are discussed, the recommendation feels like a logical next step rather than a sales pitch.

The OSDE also creates an additional medically billed encounter, helping establish the patient as a medical patient rather than solely a vision patient. As the lifetime value data demonstrates, that distinction has significant long-term implications.

Revenue Does Not Have to Happen Once a Year

Traditional optometry revenue is concentrated around annual exams and eyewear purchases.

Engaged dry eye patients behave differently.

A patient enrolled in a structured workflow may purchase a starter kit shortly after diagnosis, return for an OSDE, pursue advanced treatment, reorder products throughout the year, and remain connected to the practice through an online store.

This changes the revenue cycle entirely.

Approximately 37% of workflow-enrolled patients place repeat orders through the Peeq Pro platform. While dry eye products contribute meaningfully to this activity, specialty contact lens products are often the largest driver. Scleral lens care systems, orthokeratology solutions, and other recurring-use products create ongoing engagement between visits.

Every order represents more than revenue.

It is a touchpoint.

Patients remain connected to the practice, engaged with their treatment, and invested in their eye health. As a result, they are more likely to return for annual exams, purchase eyewear, and continue following recommended care plans.

Instead of generating revenue once per year, these patients create value throughout the year.

Building the Pathway to High-Value Services

The highest-value services in modern optometry share a common requirement.

Whether it is IPL, LipiFlow, orthokeratology, or specialty contact lens care, success depends on an informed and motivated patient.

Patients rarely commit to advanced services without first understanding their condition and believing in the importance of treatment.

The workflow helps create that foundation.

Patients who have successfully completed a home therapy program, attended an OSDE, purchased products through the practice, and experienced ongoing support arrive at treatment discussions with a completely different mindset.

They understand the problem.

They trust the provider.

They have already demonstrated a willingness to invest in improving their eye health.

When advanced treatment is recommended, acceptance rates increase because the recommendation fits naturally into a care journey that is already underway.

The same dynamic extends beyond dry eye. Orthokeratology, scleral lenses, and other specialty services all benefit from patients who are engaged, educated, and consistently connected to the practice.

The Real Goal

The goal of a successful optometry practice is not simply to see more patients.

It is to build stronger relationships with the right patients.

A patient who returns annually, participates in medical care, purchases products through your practice, receives advanced treatments, and refers friends and family creates value that extends far beyond any single visit.

Those patients become the foundation of a thriving practice.

The challenge is that many practices already have these patients in their database. They simply have not activated them yet.

They remain irregular vision patients not because they lack need, but because they have never been guided through a structured pathway that helps them recognize, treat, and manage chronic ocular surface disease.

That is the gap Peeq Pro is designed to fill.

By supporting DEWS II and DEWS III-based protocols, improving adherence, reducing no-shows, increasing OSDE attendance, strengthening patient engagement, and creating year-round purchasing opportunities, practices can transform occasional patients into long-term medical relationships.

The financial impact compounds over time.

A practice that converts just 20 irregular vision patients each year into engaged dry eye patients with ongoing medical care, product purchases, and annual compliance can add hundreds of thousands of dollars in long-term patient value.

The opportunity already exists within most practices.

The question is whether there is a system in place to capture it.

Peeq Pro partners with optometry practices to build the workflow infrastructure that improves treatment adherence, strengthens clinical outcomes, and increases patient lifetime value. To learn more, contact Tom Chapman at tchapman@getpeeq.com or (402) 850-8826.